
Bupropion Hydrochloride
150 mg/1 · Extended-Release Tablet
By Lupin Pharmaceuticals, Inc.
- NDC
- 68180-319
- Route
- Oral
- Therapeutic class
- Aminoketone , Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]
- Marketing category
- ANDA
Package sizes
- 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (68180-319-06)NDC 68180-319-06Available to order
- 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (68180-319-09)NDC 68180-319-09Available to order
- 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (68180-319-02)NDC 68180-319-02Available to order
Additional information
Full prescribing information for this product is available on request. Submit a sourcing request and our team will share lot details, dating, and current pricing.
Request this medication
Send a request and we'll respond with availability, lot details, and pricing within 2 business hours.

